Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cytoreductive chemotherapy followed by MVE-2: impact of interval between treatment modalities and therapeutic results against MBL-2 tumor

Cytoreductive chemotherapy followed by MVE-2: impact of interval between treatment modalities and therapeutic results against MBL-2 tumor. Proceedings of the AACR. 1984.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.